Ma Y, Li R, Dong Y, You C, Huang S, Li X
Int J Nanomedicine. 2021; 16:789-802.
PMID: 33568906
PMC: 7869709.
DOI: 10.2147/IJN.S289005.
Chi H, Chan V, Li C, Hsieh J, Lin P, Tsai Y
BMC Chem. 2020; 14(1):63.
PMID: 33111062
PMC: 7585315.
DOI: 10.1186/s13065-020-00711-4.
Varidaki A, Hong Y, Coffey E
Front Cell Neurosci. 2018; 12:226.
PMID: 30135644
PMC: 6092511.
DOI: 10.3389/fncel.2018.00226.
Yang L, Zheng Z, Cheng F, Ruan X, Jiang D, Pan C
Molecules. 2016; 21(10).
PMID: 27775631
PMC: 6273852.
DOI: 10.3390/molecules21101403.
Rasool S, Mohamed R
Protoplasma. 2015; 253(5):1197-209.
PMID: 26364028
DOI: 10.1007/s00709-015-0884-4.
Oxetane synthesis through the Paternò-Büchi reaction.
DAuria M, Racioppi R
Molecules. 2013; 18(9):11384-428.
PMID: 24043139
PMC: 6269742.
DOI: 10.3390/molecules180911384.
The early stages of taxol biosynthesis: an interim report on the synthesis and identification of early pathway metabolites.
Guerra-Bubb J, Croteau R, Williams R
Nat Prod Rep. 2012; 29(6):683-96.
PMID: 22547034
PMC: 3373433.
DOI: 10.1039/c2np20021j.
Supramolecular micellar nanoaggregates based on a novel chitosan/vitamin E succinate copolymer for paclitaxel selective delivery.
Lian H, Sun J, Yu Y, Liu Y, Cao W, Wang Y
Int J Nanomedicine. 2012; 6:3323-34.
PMID: 22228999
PMC: 3252679.
DOI: 10.2147/IJN.S26305.
Secondary metabolites as DNA topoisomerase inhibitors: A new era towards designing of anticancer drugs.
Baikar S, Malpathak N
Pharmacogn Rev. 2012; 4(7):12-26.
PMID: 22228937
PMC: 3249898.
DOI: 10.4103/0973-7847.65320.
Natural products synthesis: enabling tools to penetrate Nature's secrets of biogenesis and biomechanism.
Williams R
J Org Chem. 2011; 76(11):4221-59.
PMID: 21438619
PMC: 3174107.
DOI: 10.1021/jo2003693.
Natural product inhibitors of Hsp90: potential leads for drug discovery.
Amolins M, Blagg B
Mini Rev Med Chem. 2009; 9(2):140-52.
PMID: 19200020
PMC: 2659174.
DOI: 10.2174/138955709787316056.
Plant-derived natural product research aimed at new drug discovery.
Itokawa H, Morris-Natschke S, Akiyama T, Lee K
J Nat Med. 2008; 62(3):263-80.
PMID: 18425692
DOI: 10.1007/s11418-008-0246-z.
Taxol-mediated changes in fibrosarcoma-induced immune cell function: modulation of antitumor activities.
MULLINS D, Walker T, Burger C, Elgert K
Cancer Immunol Immunother. 1997; 45(1):20-8.
PMID: 9353423
PMC: 11037653.
DOI: 10.1007/s002620050396.
Crystal and molecular structure of paclitaxel (taxol).
Mastropaolo D, Camerman A, Luo Y, Brayer G, CAMERMAN N
Proc Natl Acad Sci U S A. 1995; 92(15):6920-4.
PMID: 7624344
PMC: 41442.
DOI: 10.1073/pnas.92.15.6920.
Crystal structure of 2-debenzoyl, 2-acetoxy paclitaxel (Taxol): conformation of the paclitaxel side-chain.
Gao Q, Wei J, Chen S
Pharm Res. 1995; 12(3):337-41.
PMID: 7617517
DOI: 10.1023/a:1016236014766.
Taxuspine D, a new taxane diterpene from Taxus cuspidata with potent inhibitory activity against Ca(2+)-induced depolymerization of microtubules.
Kobayashi J, Hosoyama H, Shigemori H, Koiso Y, Iwasaki S
Experientia. 1995; 51(6):592-5.
PMID: 7607303
DOI: 10.1007/BF02128750.
